Holter of Movement in Patients With Amyotrophic Lateral Sclerosis. - Trial NCT06228001
Access comprehensive clinical trial information for NCT06228001 through Pure Global AI's free database. This phase not specified trial is sponsored by Dr. Stéphanie Delstanche and is currently Recruiting. The study focuses on Amyotrophic Lateral Sclerosis. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Dr. Stéphanie Delstanche
Centre Hospitalier Régional de la Citadelle
Timeline & Enrollment
N/A
May 01, 2023
Jan 01, 2028
Primary Outcome
Difference in 95th centile of stride velocity between baseline and one year follow up- or last time point,Difference in 50th centile of stride velocity between baseline and one year follow up- or last time point,Difference in 95th centile of stride length between baseline and one year follow up- or last time point,Difference in 50th centile of stride length between baseline and one year follow up- or last time point
Summary
ActiALS is a multicentric academic study. Patients with amyotrophic lateral sclerosis (ALS)
 may be included on a voluntary basis. The investigators plan to include a group of
 approximately 30 patients with ALS.
 
 The investigators have planned to assess patient every three months for a year. After each
 visit, participants will wear Actimyo for one month daily.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06228001
Device Trial